Dr. Kristen Fortn

Dr. Kristen Fortn

Company: BIOAGE

Job title: Founder and CEO


Kristen leads BIOAGE in its mission to develop a broad pipeline of therapies that target aging in order to increase healthspan and address chronic diseases. Kristen draws from a deep background in aging research and systems biology to develop BIOAGE’s data-driven approach to identify and target the molecular pathways that drive aging. Kristen received her PhD in Medical Biophysics from the University of Toronto, followed by postdoctoral training at Stanford University where she was a fellow of the Ellison Medical Foundation / American Federation for Aging Research. She has over 10 years of experience developing novel bioinformatics approaches for data-driven investigation into the mechanisms of aging and age-related disease, with 19 published papers spanning computational drug discovery, biomarkers of aging, and the genetics of exceptional human longevity.


Data-driven Approaches to Identifying Circulating Factors That Drive Aging 4:10 pm

Exploring how omics data enables us to study aging directly in humans, rather than less translationally relevant model systems Focusing on omic phenotyping of human aging cohorts that have decades of follow-up EHRs Integrating multiple data modalities for data-driven discovery of key aging targetsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.